New Zealand markets closed

Atai Life Sciences N.V. (ATAI)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.6300-0.0300 (-1.81%)
At close: 04:00PM EDT
1.6600 +0.03 (+1.84%)
After hours: 07:51PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
277
314
233
20,376
0
-
Operating expenses
Research development
54,452
62,203
74,313
47,956
11,408
-
Selling general and administrative
62,167
63,582
70,350
92,745
80,734
-
Total operating expenses
113,969
123,340
144,663
140,701
92,142
-
Operating income or loss
-113,692
-123,026
-144,430
-120,325
-92,142
-
Interest expense
2,721
2,656
923
-
-
-
Total other income/expenses net
82,723
84,549
9,623
-16,481
-9,742
-
Income before tax
-31,811
-39,286
-135,182
-136,601
-101,813
-
Income tax expense
847
1,016
6,229
-3,989
305
-
Income from continuing operations
-36,919
-43,895
-157,417
-174,244
-178,625
-
Net income
-33,802
-40,224
-152,385
-167,808
-169,843
-
Net income available to common shareholders
-33,802
-40,224
-152,385
-167,808
-169,843
-
Basic EPS
-0.43
-
-0.98
-1.21
-1.11
-0.09
Diluted EPS
-0.43
-
-0.98
-1.21
-1.11
-0.09
Basic average shares
156,529
-
155,720
138,266
152,570
152,570
Diluted average shares
156,529
-
155,720
138,266
152,570
152,570